Navigation Links
Survival data presented from phase II study of hormone-resistant prostate cancer patients
Date:9/25/2007

Wilmington, DE, Sept. 25th 2007 The results from the randomized, double -blind, placebo -controlled, Phase II EPOC (Endothelin A Proof Of Concept) Study of ZD4054 - a specific endothelin A (ETA) receptor antagonist were delivered today at the 14th European Congress of Clinical Oncology (ECCO, 23-27 September, Barcelona). The data presented today for ZD4054, an investigational compound in development for the treatment of men with hormone resistant prostate cancer (HRPC), showed no differences in progression free survival (PFS) but did report encouraging overall survival (OS) data.

To further evaluate the potential of ZD4054 , the Phase III trial program ENTHUSE (ENDOTHELIN A USE), consisting of three studies, will begin this year. The first of these trials is aimed at investigating the efficacy of ZD4054 in metastatic HRPC, while the second will look at its role in nonmetastatic HRPC patients. A third trial will study ZD4054 in combination with docetaxel (TaxotereTM) for the treatment of metastatic HRPC.

Nick James, Professor of Clinical Oncology, Institute for Cancer Studies, Birmingham, UK, and principal investigator of the EPOC study said: Men with advanced prostate cancer are typically treated with hormonal therapies. Whilst these therapies can provide great benefits, most men will become resistant to them. Currently, the only licensed treatment option for metastatic patients shown to improve survival in men with HRPC is chemotherapy with docetaxel.

The results from the EPOC study suggest that ZD4054 10 mg once daily may have the potential to increase the median overall survival time for men with asymptomatic or mildly symptomatic metastatic HRPC.

EPOC (Endothelin A Proof Of Concept) Phase II findings:

The primary endpoint of the study was progression free survival (PFS) and a secondary endpoint was Overall Survival (OS). The PFS data did not show a statistically significant difference between ZD4054 and pla
'/>"/>

Contact: Asa Josefsson
Asa.Josefsson@astrazeneca.com
302-885-4109
Edelman Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Long-Term Survival can be Predicted by a Simple Lung Test
2. Survival Of Colon Cancer Patients
3. Hepatitis G May Boost HIV Survival
4. Zinc supplements improve survival rate
5. Magnesium no benefit of survival after heart attack
6. Specialist care convalesces intensive care survival
7. Prolonged survival not assured by psychological therapies for cancer patients
8. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
9. Longer Lung Cancer Survival
10. ICU Survival can be improved by Antibiotic use
11. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... study suggests that disturbed sleep in adolescents is ... uncertainly about future success. However, perceived support ... have a protective effect. , Results show ... mood and greater uncertainty about future success. Higher ... teachers were associated with significantly fewer sleep disruptions ...
(Date:5/22/2013)... the parents are married are less likely to be ... the University of Houston. , "Childhood obesity is a ... one-third of all U.S. children ages 2-17 overweight or ... sociology at Rice and director of Rice,s Kinder Institute ... been conducted to explore the impact of family structure ...
(Date:5/22/2013)... May 22, 2013 Slip and fall ... by a number of factors. A December 2010 CDC ... following hazards as the most common: contaminants on the ... weather conditions, inadequate lighting, and lack of handrails (i). ... bruises, strained ligaments and muscles, fractures, broken bones, ...
(Date:5/22/2013)... Monroe, OH (PRWEB) May 22, 2013 ... indoor air quality merchandise ranging from furnace filters, ... DiscountFurnaceFilters.com is excited to add Stadler Form's ... a fashionable summer product line (fans, aroma diffusers ... , Stadler Form’s Otto Fan is the perfect ...
(Date:5/22/2013)... Peak Solar introduces unique, interactive solar training seminars, ... customers make informed buying choices. Research studies tell companies ... is to give them the tools needed to make ... heart. Solar training seminars will be introduced onto the ... solar kits . , Poised to help both residential ...
Breaking Medicine News(10 mins):Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 2Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 3Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2
... consumer focused new and improved interface. The most highlighting feature of ... cyber consumers to choose and buy their niche medicines any time. ... ... USA,s most reliable online pharmacy, launched a brand new customer focused, ...
... Multiple customer agreements for Soarian Clinicals and Siemens ... for the system that streamlines the flow of ... 5 Siemens ( ... customer contracts and installations, along with strong existing-customer ...
... allergies, so be prepared, expert says , , SUNDAY, April ... child is one of the more than 35 million Americans ... the youngster enjoy being outside, one expert says. , ... with MCG Pediatric Primary Care Associates and MCGHealth Children,s Medical ...
... of a Post-Merger Integration and Restructuring Practice. The new practice ... posed by increasing financial pressures and the consolidating health care market. ... ... Health Strategies & Solutions, Inc. (HS&S), the nation,s leading health ...
... man that suffers from depression, erectile dysfunction, fatigue, poor concentration or hot ... is advising men ages 35 and over to have their hormone levels ... 4 out of 5 men age 40 have low testosterone, the leading ... ...
... Mass., April 4 Inverness Medical Innovations, Inc. (NYSE: ... individuals to take charge of their health at home ... announced today that it will attend the upcoming Goldman ... Wednesday, April 8, 2009 at the Goldman Sachs Conference ...
Cached Medicine News:Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 2Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 3Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 2Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 3Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 4Health News:Breathe Easier Knowing Spring's Pollen Triggers 2Health News:The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice 2Health News:The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice 3Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 2Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 3Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 4
(Date:5/22/2013)... 22, 2013 Hemoglobin A1C levels increased ... Type 2 diabetes, while modest improvements in A1C ... and can lead to substantial healthcare cost savings, ... Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th ... sponsored by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... at the following conferences. , Deutsche Bank 38th ... 29, 2013 , Presentation time: 12:00 p.m. P.T. ... Presentation date: Wednesday June 5, 2013 , Presentation time: ... live webcast and 30-day archive of these presentations will be ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... Nov. 18, 2011 A new report released by ... spending on medical imaging is declining and Medicare patients ...  This analysis confirms earlier findings released by the American ... of the Coalition for Patient-Centered Imaging demonstrating that the ...
... 18, 2011 MedSolutions , a leading ... announced the launch of its Implantable Cardioverter Defibrillator ... to ensure the clinical appropriateness of ICD and ... With the cost of each ICD/CRT-D procedure averaging ...
Cached Medicine Technology:New Analysis Shows Downward Trend in Imaging Utilization 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: